Displaying items by tag: GenAI study

Data privacy and security are leading concerns in highly regulated industries

Generative AI is at the forefront of global innovation in both health care and life sciences. To better understand how technology is being used, data and AI leader SAS and Coleman Parkes Research conducted a global, cross-industry survey of 237 life sciences and pharma leaders and 240 health care leaders who are decision makers on their organisation's GenAI, data and analytics strategy.

Published in Health

Subscribe to Newsletter

*  Enter the security code shown: img0

CYBERSECURITY

PEOPLE MOVES

GUEST ARTICLES

Guest Opinion

ITWIRETV & INTERVIEWS

RESEARCH & CASE STUDIES

Channel News

Comments